Skip to main content


Welcome to The Happy Lungs Project Blog. Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET research.

We seek to support researchers and clinicians in their work toward a cure for Non-Small Cell Lung Cancer caused by the RET mutation. We also aim to provide community resources and events to support finding a cure for RET Positive Lung Cancer. On this blog, you will find information about our research, RET clinical trials, patient stories and upcoming events.

We would like to also welcome our guest blogger, Anthony “Nino” Sireci, M.D., vice president, clinical biomarker and diagnostics development at Lilly. Read Nino’s News.


REt positive lung cancer treatment options in 2024, ret gene and ret fusions

Current Treatment Options for RET Lung Cancer

Lung cancer staging matters. Why? So your doctor can properly assess the spread of disease…
June 5, 2024
biomarker testing RET cancer

Finding the Right Time to Ask About Biomarker Testing

Increasingly, cancer care is being approached with precision medicine methods that can offer personalized medical…
July 27, 2023
cancer medical care team

Understanding the Role of a Care Team in Treatment Planning

When someone is diagnosed with cancer, it is critical that they and their caregivers take…
April 18, 2023
RET lung cancer research survey 2024

Results From Our Spring 2024 Survey

What we learned, and what’s next: Scientific research can be confusing and overwhelming, and that’s…
May 29, 2024
together separately live stream

IASLC Targeted Therapies Recap

#TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…
March 11, 2024
elipses pharma ep0031

RET inhibitor Granted Fast Track by FDA

Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by FDA Ellipses Pharma…
March 11, 2024
harmonic never smoker lung cancer trial

The Harmonic™ Clinical Trial for Never Smokers

New clinical trial for never smokers: The Harmonic™ clinical trial The Harmonic™ clinical trial is…
March 9, 2024
oncogene testing RET lung cancer

Looking Ahead: The Future of Diagnostic Testing for Patients

Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…
January 7, 2024
ret cancer research 2023

2023 RET Cancer Research Update

2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…
December 18, 2023
RET lung cancer study 2023

Exciting Preclinical Results About Vepafestinib

New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06).  Vepafestinib showed selectivity…
October 10, 2023
lung cancer research

New clinical trial testing amivantamab

New clinical trial testing amivantamab for patients who progressed on RET therapies:  A Phase 1…
October 8, 2023
on and off target ret resistance

Two research studies funded by HLP presented at 2023 ASCO Mtg

Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…
June 19, 2023

Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors

Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…
June 19, 2023

DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies

The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…
June 19, 2023
2022 ret cancer research update happy lungs project

Virtual Event: 2022 RET Cancer Research Update (Watch Video)

The Happy Lungs Project hosted a 2022 Research Update, featuring presentations about advances for RET-positive…
December 13, 2022